Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 55:356-366, 2006
DOI: 10.2337/diabetes.55.02.06.db05-0702
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Inagi, R.
Right arrow Articles by Miyata, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Inagi, R.
Right arrow Articles by Miyata, T.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Complications

A Severe Diabetic Nephropathy Model With Early Development of Nodule-Like Lesions Induced by Megsin Overexpression in RAGE/iNOS Transgenic Mice

Reiko Inagi1, Yasuhiko Yamamoto2, Masaomi Nangaku3, Nobuteru Usuda4, Hiroshi Okamato5, Kiyoshi Kurokawa1, Charles van Ypersele de Strihou6, Hiroshi Yamamoto2, and Toshio Miyata1

1 Institute of Medical Sciences and Division of Nephrology, Hypertension and Metabolism, Tokai University School of Medicine, Kanagawa, Japan
2 Department of Biochemistry and Molecular Vascular Biology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
3 Division of Nephrology and Endocrinology, University of Tokyo School of Medicine, Tokyo, Japan
4 Department of Anatomy, Fujita Health University School of Medicine, Aichi, Japan
5 Department of Advanced Biological Sciences for Regeneration, Tohoku University Graduate School of Medicine, Miyagi, Japan
6 Service de Nephrologie, Universite Catholique de Louvain, Brussels, Belgium

Address correspondence and reprint requests to Toshio Miyata, MD, PhD, Institute of Medical Sciences and Division of Nephrology, Hypertension and Metabolism, Tokai University School of Medicine, Isehara, Kanagawa 259-1193, Japan. E-mail: t-miyata{at}is.icc.u-tokai.ac.jp

Key Words: AGE, advanced glycation end product • CML, carboxymethyllysine • ELISA, enzyme-linked immunosorbent assay • iNOS, inducible nitric oxide synthase • 8-OHdG, 8-hydroxy-deoxyguanosine • PAM, periodic acid–methenamine silver • PAS, periodic acid Schiff • RAGE, receptor for advanced glycation end products • {alpha}-SMA, {alpha}-smooth muscle actin

Many factors are involved in the pathogenesis of diabetic nephropathy. A single gene abnormality may be prerequisite but insufficient to the disease to manifest. It is therefore only when a second or sometimes a third damage is associated that the consequences of pathogenic phenotypes become evident. We generated the triple transgenic mice overexpressing megsin (a novel glomerular-specific serpin), a receptor for advanced glycation end products (RAGE), and inducible nitric oxide synthase (iNOS). Compared with the single- or two-gene transgenic mice, the triple transgenic mice developed, at an early age (16 weeks), severe albuminuria and renal damage with all of the characteristics of human diabetic nephropathy (i.e., glomerular hypertrophy, diffuse mesangial expansion, inflammatory cell infiltration, and interstitial fibrosis). Interestingly, 30–40% of glomeruli exhibit nodule-like lesions. Oxidative and carbonyl stress makers (pentosidine, N{varepsilon}-carboxymethyllysine, and 8-hydroxy-deoxyguanosine) were significantly higher in the triple transgenic mice. The iNOS transgenic mice have a diabetes phenotype, the renal consequences of which are moot, and the superimposition of RAGE leads to more conspicuous manifestations. By additional overexpression of megsin, a gene known to be involved in mesangial proliferation and expansion, these local consequences become dramatically manifest and approximate those observed in human pathology. This multiple hit approach is of interest in consideration of the sequential events during development of diabetic nephropathy.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
J. M. Forbes, M. T. Coughlan, and M. E. Cooper
Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes
Diabetes, June 1, 2008; 57(6): 1446 - 1454.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
R. Inagi, Y. Izuhara, N. Tominaga, M. Nangaku, K. Kurokawa, and T. Miyata
Establishment of a sandwich ELISA for human megsin, a kidney-specific serine protease inhibitor
Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3311 - 3317.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.